Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Hepatitis B virus (HBV) reactivation in an acute lymphoblastic leukemia patient despite being vaccinated against HBV in infancy.

Yamamoto M, Ikuta K, Sawada K, Shindo M, Torimoto Y, Okumura T.

Dig Liver Dis. 2019 Jul 30. pii: S1590-8658(19)30687-5. doi: 10.1016/j.dld.2019.07.003. [Epub ahead of print] No abstract available.

PMID:
31371272
2.

Pseudogout Attack after Pegfilgrastim Administration in Anaplastic Large Cell Lymphoma.

Hatayama M, Ikuta K, Ishioh M, Saito T, Toki Y, Yamamoto M, Shindo M, Torimoto Y, Okumura T.

Intern Med. 2018 Jun 15;57(12):1779-1782. doi: 10.2169/internalmedicine.9362-17. Epub 2018 Feb 9.

3.

A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study).

Kobayashi T, Nannya Y, Ichikawa M, Oritani K, Kanakura Y, Tomita A, Kiyoi H, Kobune M, Kato J, Kawabata H, Shindo M, Torimoto Y, Yonemura Y, Hanaoka N, Nakakuma H, Hasegawa D, Manabe A, Fujishima N, Fujii N, Tanimoto M, Morita Y, Matsuda A, Fujieda A, Katayama N, Ohashi H, Nagai H, Terada Y, Hino M, Sato K, Obara N, Chiba S, Usuki K, Ohta M, Imataki O, Uemura M, Takaku T, Komatsu N, Kitanaka A, Shimoda K, Watanabe K, Tohyama K, Takaori-Kondo A, Harigae H, Arai S, Miyazaki Y, Ozawa K, Kurokawa M; for National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Am J Hematol. 2017 Dec;92(12):1324-1332. doi: 10.1002/ajh.24905. Epub 2017 Sep 28.

4.

Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report.

Yamamoto M, Ikuta K, Toki Y, Hatayama M, Shindo M, Torimoto Y, Okumura T.

Medicine (Baltimore). 2017 Sep;96(36):e8001. doi: 10.1097/MD.0000000000008001.

5.

A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/Lymphoma.

Iyama S, Sato T, Ohnishi H, Kanisawa Y, Ohta S, Kondo T, Mori A, Tsutsumi Y, Kuroda H, Kakinoki Y, Yamamoto S, Takahashi T, Shindo M, Torimoto Y, Sato K, Iwasaki H, Haseyama Y, Kohda K, Nagamachi Y, Hirayama Y, Sakai H, Hirata Y, Fukuhara T, Ikeda H, Kobune M, Kato J, Kurosawa M.

Clin Lymphoma Myeloma Leuk. 2017 Jan;17(1):23-30.e2. doi: 10.1016/j.clml.2016.09.009. Epub 2016 Sep 17.

PMID:
27727135
6.

Iron-induced epigenetic abnormalities of mouse bone marrow through aberrant activation of aconitase and isocitrate dehydrogenase.

Yamamoto M, Tanaka H, Toki Y, Hatayama M, Ito S, Addo L, Shindo M, Sasaki K, Ikuta K, Ohtake T, Fujiya M, Torimoto Y, Kohgo Y.

Int J Hematol. 2016 Oct;104(4):491-501. doi: 10.1007/s12185-016-2054-7. Epub 2016 Jul 5.

PMID:
27380194
7.

A selective splicing variant of hepcidin mRNA in hepatocellular carcinoma cell lines.

Toki Y, Sasaki K, Tanaka H, Yamamoto M, Hatayama M, Ito S, Ikuta K, Shindo M, Hasebe T, Nakajima S, Sawada K, Fujiya M, Torimoto Y, Ohtake T, Kohgo Y.

Biochem Biophys Res Commun. 2016 Aug 5;476(4):501-507. doi: 10.1016/j.bbrc.2016.05.153. Epub 2016 Jun 2.

8.

Current therapeutic strategies for multiple myeloma.

Torimoto Y, Shindo M, Ikuta K, Kohgo Y.

Int J Clin Oncol. 2015 Jun;20(3):423-30. doi: 10.1007/s10147-015-0826-3. Epub 2015 Apr 9. Review.

PMID:
25855312
9.

[Anemia].

Torimoto Y, Ikuta K, Shindo M.

Nihon Rinsho. 2015 Feb;73 Suppl 2:341-4. Japanese. No abstract available.

PMID:
25831779
10.

Hepatic nerve growth factor induced by iron overload triggers defenestration in liver sinusoidal endothelial cells.

Addo L, Tanaka H, Yamamoto M, Toki Y, Ito S, Ikuta K, Sasaki K, Ohtake T, Torimoto Y, Fujiya M, Kohgo Y.

Biochim Biophys Acta. 2015 Jan;1852(1):175-83. doi: 10.1016/j.bbadis.2014.11.014. Epub 2014 Nov 21.

11.

[Case report; Two cases of paroxysmal nocturnal hemoglobinuria with preceding cytopenia].

Inamura J, Ikuta K, Toki Y, Hatayama M, Ito S, Shindo M, Sato K, Torimoto Y, Kohgo Y.

Nihon Naika Gakkai Zasshi. 2014 Jun 10;103(6):1385-7. Japanese. No abstract available.

PMID:
25151804
12.

Non-transferrin-bound iron assay system utilizing a conventional automated analyzer.

Ito S, Ikuta K, Kato D, Shibusa K, Niizeki N, Tanaka H, Addo L, Toki Y, Hatayama M, Inamura J, Shindo M, Sasaki K, Iizuka N, Fujiya M, Torimoto Y, Kohgo Y.

Clin Chim Acta. 2014 Nov 1;437:129-35. doi: 10.1016/j.cca.2014.07.013. Epub 2014 Jul 27.

PMID:
25072389
13.

Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group.

Hirayama Y, Ishitani K, Ota S, Kurosawa M, Kondo T, Takimoto R, Mori A, Sakai H, Torimoto Y, Yamamoto S, Sato K, Iwasaki H, Kohda K, Ishida T, Kakinoki Y, Fukuhara T, Kato J.

Int J Hematol. 2014 Sep;100(3):281-9. doi: 10.1007/s12185-014-1629-4. Epub 2014 Jul 23.

PMID:
25052874
14.

Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib.

Takahashi N, Miura M, Kuroki J, Mitani K, Kitabayashi A, Sasaki O, Kimura H, Imai K, Tsukamoto N, Noji H, Kondo T, Motegi M, Kato Y, Mita M, Saito H, Yoshida C, Torimoto Y, Kimura T, Wano Y, Nomura J, Yamamoto S, Mayama K, Honma R, Sugawara T, Sato S, Shinagawa A, Abumiya M, Niioka T, Harigae H, Sawada K.

Biomark Res. 2014 Mar 20;2(1):6. doi: 10.1186/2050-7771-2-6.

15.

Risk factor analysis of non-Hodgkin lymphoma-associated haemophagocytic syndromes: a multicentre study.

Sano H, Kobayashi R, Tanaka J, Hashino S, Ota S, Torimoto Y, Kakinoki Y, Yamamoto S, Kurosawa M, Hatakeyama N, Haseyama Y, Sakai H, Sato K, Fukuhara T.

Br J Haematol. 2014 Jun;165(6):786-92. doi: 10.1111/bjh.12823. Epub 2014 Mar 10.

PMID:
24606577
16.

Hepcidin production in response to iron is controlled by monocyte-derived humoral factors.

Sasaki Y, Shimonaka Y, Ikuta K, Hosoki T, Sasaki K, Torimoto Y, Kanada H, Moriguchi Y, Kohgo Y.

Int J Hematol. 2014 Jan;99(1):12-20. doi: 10.1007/s12185-013-1476-8. Epub 2013 Dec 1.

PMID:
24293278
17.

Etoposide-containing conditioning regimen reduces the occurrence of hemophagocytic lymphohistiocytosis after SCT.

Kobayashi R, Tanaka J, Hashino S, Ota S, Torimoto Y, Kakinoki Y, Yamamoto S, Kurosawa M, Hatakeyama N, Haseyama Y, Sakai H, Sato K, Fukuhara T.

Bone Marrow Transplant. 2014 Feb;49(2):254-7. doi: 10.1038/bmt.2013.145. Epub 2013 Sep 16.

PMID:
24037021
18.

Ex vivo activation of angiogenic property in human peripheral blood-derived monocytes by thrombopoietin.

Kawamoto T, Sasajima J, Sugiyama Y, Nakamura K, Tanabe H, Fujiya M, Nata T, Iuchi Y, Ashida T, Torimoto Y, Mizukami Y, Kohgo Y.

Int J Hematol. 2013 Oct;98(4):417-29. doi: 10.1007/s12185-013-1423-8. Epub 2013 Sep 4.

PMID:
24002641
19.

Upregulation of iron regulatory hormone hepcidin by interferon α.

Ichiki K, Ikuta K, Addo L, Tanaka H, Sasaki Y, Shimonaka Y, Sasaki K, Ito S, Shindo M, Ohtake T, Fujiya M, Torimoto Y, Kohgo Y.

J Gastroenterol Hepatol. 2014 Feb;29(2):387-94. doi: 10.1111/jgh.12348.

PMID:
23926964
20.

A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group.

Torimoto Y, Sato K, Ikuta K, Hayashi T, Hirayama Y, Inamura J, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Mori A, Ota S, Sakai H, Shigematsu A, Shindo M, Shinzaki H, Takahashi F, Takimoto R, Tanaka J, Yamamoto S, Kohgo Y, Fukuhara T.

Int J Hematol. 2013 Aug;98(2):171-8. doi: 10.1007/s12185-013-1383-z. Epub 2013 Jun 29.

PMID:
23813410
21.

Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.

Kurosawa M, Yonezumi M, Hashino S, Tanaka J, Nishio M, Kaneda M, Ota S, Koda K, Suzuki N, Yoshida M, Hirayama Y, Takimoto R, Torimoto Y, Mori A, Takahashi T, Iizuka S, Ishida T, Kobayashi R, Oda T, Sakai H, Yamamoto S, Takahashi F, Fukuhara T.

Int J Hematol. 2012 Dec;96(6):748-57. doi: 10.1007/s12185-012-1210-y. Epub 2012 Oct 31.

PMID:
23111539
22.
23.

[Case report: a case of pure red cell aplasia associated with pregnancy].

Ito S, Ikuta K, Yamamoto M, Okamura N, Ichiki K, Sugiyama J, Shindo M, Torimoto Y, Kohgo Y.

Nihon Naika Gakkai Zasshi. 2012 Jul 10;101(7):2042-4. Japanese. No abstract available.

PMID:
22897008
24.

Iron facilitator LS081 reduces hypoxia-inducible factor-1α protein and functions as anticancer agent in hepatocellular carcinoma.

Tanaka H, Li Z, Ikuta K, Addo L, Akutsu H, Nakamura M, Sasaki K, Ohtake T, Fujiya M, Torimoto Y, Glass J, Kohgo Y.

Cancer Sci. 2012 Apr;103(4):767-74. doi: 10.1111/j.1349-7006.2011.02192.x. Epub 2012 Jan 29.

25.

Recurrent lesion of mantle cell lymphoma in the sigmoid colon detected by endoscopic autofluorescence imaging.

Ikuta K, Fujiya M, Hatayama M, Ueno N, Moriichi K, Torimoto Y, Kohgo Y.

Endoscopy. 2011;43 Suppl 2 UCTN:E330-1. doi: 10.1055/s-0030-1256776. Epub 2011 Oct 21. No abstract available.

PMID:
22020711
26.

Interference of deferasirox with assays for serum iron and serum unsaturated iron binding capacity during iron chelating therapy.

Ikuta K, Ito S, Tanaka H, Sasaki K, Torimoto Y, Fujiya M, Kohgo Y.

Clin Chim Acta. 2011 Nov 20;412(23-24):2261-6. doi: 10.1016/j.cca.2011.08.020. Epub 2011 Aug 22.

PMID:
21884685
27.

Improved quantification for non-transferrin-bound iron measurement using high-performance liquid chromatography by reducing iron contamination.

Sasaki K, Ikuta K, Tanaka H, Ohtake T, Torimoto Y, Fujiya M, Kohgo Y.

Mol Med Rep. 2011 Sep-Oct;4(5):913-8. doi: 10.3892/mmr.2011.518. Epub 2011 Jun 27.

PMID:
21720715
28.

Development of POEMS syndrome after an initial manifestation of solitary plasmacytoma.

Shindo M, Sato K, Yamamoto M, Toki Y, Hatayama M, Ito S, Ichiki K, Okamura N, Hosoki T, Ikuta K, Inamura J, Watanabe S, Torimoto Y, Kohgo Y.

Int J Hematol. 2011 Jun;93(6):815-821. doi: 10.1007/s12185-011-0863-2. Epub 2011 May 7. Review.

PMID:
21553018
29.

Loss of ABCB7 gene: pathogenesis of mitochondrial iron accumulation in erythroblasts in refractory anemia with ringed sideroblast with isodicentric (X)(q13).

Sato K, Torimoto Y, Hosoki T, Ikuta K, Takahashi H, Yamamoto M, Ito S, Okamura N, Ichiki K, Tanaka H, Shindo M, Hirai K, Mizukami Y, Otake T, Fujiya M, Sasaki K, Kohgo Y.

Int J Hematol. 2011 Mar;93(3):311-318. doi: 10.1007/s12185-011-0786-y. Epub 2011 Mar 8.

PMID:
21380928
30.

Detection of soluble HFE associated with soluble transferrin receptor in human serum.

Ohnishi K, Torimoto Y, Ikuta K, Tanaka H, Hosoki T, Tanaka S, Hamano A, Sato K, Fujiya M, Sasaki K, Kohgo Y.

Int J Mol Med. 2011 Mar;27(3):435-9. doi: 10.3892/ijmm.2010.584. Epub 2010 Dec 16.

PMID:
21165552
31.

Heterogeneous expressions of hepcidin isoforms in hepatoma-derived cells detected using simultaneous LC-MS/MS.

Hosoki T, Ikuta K, Shimonaka Y, Sasaki Y, Yasuno H, Sato K, Ohtake T, Sasaki K, Torimoto Y, Saito K, Kohgo Y.

Proteomics Clin Appl. 2009 Nov;3(11):1256-64. doi: 10.1002/prca.200900112.

PMID:
21136948
32.

Successful treatment of systemic Geotrichum capitatum infection by liposomal amphotericin-B, itraconazole, and voriconazole in a Japanese man.

Ikuta K, Torimoto Y, Yamamoto M, Okamura N, Hosoki T, Sato K, Fujiya M, Kohgo Y.

Intern Med. 2010;49(22):2499-503. Epub 2010 Nov 15.

33.

An unusual elevated lesion of the oesophagus.

Sawada K, Ikuta K, Itabashi K, Suzuki Y, Mizukami Y, Fujiya M, Kubo K, Tamura Y, Torimoto Y, Kohgo Y.

Gut. 2011 Apr;60(4):441, 516. doi: 10.1136/gut.2009.186650. Epub 2010 Aug 30. No abstract available.

PMID:
20805307
34.

Atypical mucosa-associated lymphoid tissue lymphoma in the transverse colon associated with macroglobulinemia.

Ikuta K, Fujiya M, Ueno N, Hosoki T, Moriichi K, Honda M, Torimoto Y, Yamochi T, Ota H, Kohgo Y.

Intern Med. 2010;49(7):677-82. Epub 2010 Apr 1.

35.

Atypical Takayasu arteritis with solitary stenosis in the short segment of right axillary artery.

Ikuta K, Torimoto Y, Shindo M, Sato K, Kohgo Y.

Rheumatol Int. 2010 Nov;30(12):1635-7. doi: 10.1007/s00296-009-1110-5. Epub 2009 Aug 23.

PMID:
19701753
36.

Current topics and perspectives on malignant lymphoma. Introduction.

Kohgo Y, Torimoto Y.

Int J Clin Oncol. 2009 Jun;14(3):179-80. doi: 10.1007/s10147-009-0906-3. Epub 2009 Jul 11. No abstract available.

PMID:
19593606
37.

Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.

Onozawa M, Hashino S, Haseyama Y, Hirayama Y, Iizuka S, Ishida T, Kaneda M, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Masauji N, Matsunaga T, Mori A, Mukai M, Nishio M, Noto S, Ota S, Sakai H, Suzuki N, Takahashi T, Tanaka J, Torimoto Y, Yoshida M, Fukuhara T.

Biol Blood Marrow Transplant. 2009 Jun;15(6):724-9. doi: 10.1016/j.bbmt.2009.03.003.

38.

Electrochemical catalytic reforming of oxygenated-organic compounds: a highly efficient method for production of hydrogen from bio-oil.

Yuan L, Chen Y, Song C, Ye T, Guo Q, Zhu Q, Torimoto Y, Li Q.

Chem Commun (Camb). 2008 Nov 7;(41):5215-7. doi: 10.1039/b810851j. Epub 2008 Sep 10.

PMID:
18956073
39.

[Malignant lymphoma. Physiopathology and treatment. 6. Peripheral T cell lymphoma].

Sato K, Torimoto Y, Kogo Y.

Nihon Naika Gakkai Zasshi. 2008 Jul 10;97(7):1611-9. Japanese. No abstract available.

PMID:
18720603
40.

[Cyclophosphamide and CYP2B6].

Torimoto Y, Kohgo Y.

Gan To Kagaku Ryoho. 2008 Jul;35(7):1090-3. Japanese.

PMID:
18633247
41.

Body iron metabolism and pathophysiology of iron overload.

Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J.

Int J Hematol. 2008 Jul;88(1):7-15. doi: 10.1007/s12185-008-0120-5. Epub 2008 Jul 2. Review.

42.

A novel five-way chromosomal translocation observed in chronic myelogenous leukemia.

Ikuta K, Torimoto Y, Jimbo J, Inamura J, Hosoki T, Shindo M, Sato K, Takahashi H, Kohgo Y.

Cancer Genet Cytogenet. 2008 May;183(1):69-71. doi: 10.1016/j.cancergencyto.2008.02.002.

PMID:
18474301
43.

Induction of leukemia-specific antibodies by immunotherapy with leukemia-cell-derived heat shock protein 70.

Jimbo J, Sato K, Hosoki T, Shindo M, Ikuta K, Torimoto Y, Kohgo Y.

Cancer Sci. 2008 Jul;99(7):1427-34. doi: 10.1111/j.1349-7006.2008.00829.x. Epub 2008 Apr 29.

44.

Dysregulation of systemic iron metabolism in alcoholic liver diseases.

Kohgo Y, Ohtake T, Ikuta K, Suzuki Y, Torimoto Y, Kato J.

J Gastroenterol Hepatol. 2008 Mar;23 Suppl 1:S78-81. doi: 10.1111/j.1440-1746.2007.05290.x. Review.

PMID:
18336670
45.

[Iron metabolism and anemia].

Ikuta K, Torimoto Y, Kohgo Y.

Nihon Rinsho. 2008 Mar;66(3):469-74. Review. Japanese.

PMID:
18326317
46.

Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance.

Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J.

World J Gastroenterol. 2007 Sep 21;13(35):4699-706. Review.

47.

Inactivation of Escherichia coli by O- water.

Wang L, Gong L, Zhao E, Yu Z, Torimoto Y, Sadakata M, Li QX.

Lett Appl Microbiol. 2007 Aug;45(2):200-5.

48.

[Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].

Shindo M, Sato K, Jimbo J, Hosoki T, Ikuta K, Sano A, Nishimura K, Torimoto Y, Kohgo Y.

Rinsho Ketsueki. 2007 May;48(5):412-7. Japanese.

PMID:
17571588
49.

Combined use of dendritic cells enhances specific antileukemia immunity by leukemia cell-derived heat shock protein 70 in a mouse model with minimal residual leukemia cells.

Iuchi Y, Torimoto Y, Sato K, Tamura Y, Jimbo J, Inamura J, Shindo M, Ikuta K, Ohnishi K, Kohgo Y.

Int J Hematol. 2006 Dec;84(5):449-58.

PMID:
17189229
50.

Donor-type myelodysplastic syndrome with t(2;3) and monosomy 7 after allogeneic peripheral blood stem cell transplantation and liver transplantation in a patient with severe-type aplastic anemia.

Hashino S, Fujisawa F, Kondo T, Imamura M, Sato K, Torimoto Y, Kohgo Y, Kimura K, Furukawa H, Todo S, Asaka M.

Int J Hematol. 2006 Nov;84(4):363-6.

PMID:
17118765

Supplemental Content

Loading ...
Support Center